Table of Contents
As Alzheimer’s disease affects more and more people, there is hope thanks to research and new treatments that are emerging. Dr. Kierzek explains these new advances to us.
The European Medicines Agency approved the treatment on November 14 This groupafter an initial rejection in July. A new hope For patients with Alzheimer’s disease, however, challenges remain, particularly regarding costs and side effects.
Promising new treatments
Leqembi is intended for people with early-stage Alzheimer’s disease and aims to slow cognitive decline. It is recommended for patients with:
- Mild cognitive impairment or mild dementia due to Alzheimer’s;
- Lower risk of brain hemorrhage.
This treatment works by reducing amyloid plaques in the brain. Clinical trials have shown a reduction in cognitive and functional decline by 35% after 18 months of treatment. At the same time, another promising treatment, Kisunla, was approved by the US FDA in July 2024, providing another option for patients.
To listen
Broadcast on 08/10/2024
Preventing Alzheimer’s disease: foods to favor and avoid
Despite progress, challenges persist
Despite therapeutic progress, several challenges remain to be overcome for effective care patients:
- The high cost treatments;
- The need to diagnose the disease at an early stage to maximize the effectiveness of treatments;
- Managing side effects potentially serious.
These advances bring a new hope to the millions of people affected by Alzheimer’s disease, while emphasizing the importance of continue research efforts in this area.
To listen
Broadcast from 01/10/2024
Memory loss: when to worry and how to improve it?
The advice of Dr. Gérald Kierzek
Find advice from Doctor Kierzek every morning at 8:50 a.m. From managing our stress to our nutrition and even our sleep, he gives you good advice on every aspect of our daily life.
You can also find this column replayed on the HERE app and the Radio France app.
**What are the two main challenges discussed in the interview regarding the newly approved Alzheimer’s treatments?**
## World Today News Interview: Hope & Challenges for Alzheimer’s Treatment
**Introduction**
Welcome to World Today News. Today, we’re discussing a topic close to many hearts: the advancements in Alzheimer’s disease treatment. Joining us are Dr. Sophie Leclerc, a leading neurologist specializing in dementia care, and Mr. Thomas Ashton, a patient advocate and founder of the Alzheimer’s Support Network.
**Section 1: New Treatments, New Hope**
**(Interviewer):** Dr. Leclerc, the recent approval of Leqembi by the European Medicines Agency has generated excitement. Could you share your perspective on this breakthrough and what it signifies for patients with early-stage Alzheimer’s?
**(Dr. Leclerc):**
**(Interviewer): ** Mr. Ashton, how has the news of these new treatments been received within the Alzheimer’s community? What are the hopes and expectations among patients and their families?
**(Mr. Ashton):**
**Section 2: Navigating the Challenges**
**(Interviewer):** Dr. Leclerc, while these treatments offer hope, the article highlights significant challenges, particularly regarding cost and side effects. How can we ensure equitable access to these potentially life-changing therapies?
**(Dr. Leclerc):**
**(Interviewer): ** Mr. Ashton, from a patient’s perspective, what are the main concerns surrounding these new treatments? How can we address these concerns effectively?
**(Mr. Ashton):**
**Section 3: The Importance of Early Diagnosis and Ongoing Research**
**(Interviewer):** Dr. Leclerc, the article emphasizes the critical role of early diagnosis for maximizing treatment effectiveness. What steps can individuals take to be proactive about their brain health and seek timely evaluation?
**(Dr. Leclerc):**
**(Interviewer):** Looking forward, what are the most promising avenues for research in Alzheimer’s treatment? What breakthroughs could we expect to see in the coming years?
**(Dr. Leclerc):**
**(Interviewer):** Mr. Ashton, what message would you share with individuals and families concerned about Alzheimer’s disease? What resources are available to provide support and guidance?
**(Mr. Ashton):**
**Conclusion**
Thank you, Dr. Leclerc and Mr. Ashton, for sharing your insightful perspectives on this important topic. As research progresses and treatments evolve, we can remain hopeful for a future where Alzheimer’s disease no longer casts a shadow over millions of lives. For more information and resources, please visit the links provided on our website.
**(Interviewer):** Don’t forget to tune in tomorrow when we’ll be discussing the latest developments in cancer research.
This interview format prioritizes open-ended, thought-provoking questions that encourage in-depth discussion and allow for diverse viewpoints. It aims to provide a comprehensive understanding of the advancements and challenges surrounding Alzheimer’s treatment while offering hope and guidance to those affected by this complex disease.
